GNH USA

Europe — EMA

Noradrenalina Tartrato Hameln (Noradrenaline Tartrate)

GNH USA supplies Noradrenalina Tartrato Hameln (Noradrenaline), a sympathomimetic vasopressor for hypotension and septic shock. Request a quote for supply.

Noradrenaline Tartrate

Request sourcing

1
Pack/s

What is Noradrenaline Tartrate?

Noradrenaline tartrate, the active ingredient in Noradrenalina Tartrato Hameln, is a sympathomimetic amine presented as a sterile injectable solution for intravenous use. It acts as a vasopressor to raise blood pressure in patients with hypotension or septic shock and is administered under medical supervision in acute care settings.

GNH USA supplies Noradrenalina Tartrato Hameln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. Our distribution network ensures timely delivery and regulatory compliance across EU and global markets.

What is Noradrenaline Tartrate used for?

Noradrenaline tartrate is used as a vasopressor acting on the sympathetic adrenergic system to treat severe hypotension. - Hypotension: restores adequate arterial pressure in acute low‑blood‑pressure states. - Septic shock: supports circulatory function when sepsis causes profound vasodilation. - Cardiogenic shock: helps maintain perfusion pressure when cardiac output is insufficient.

What are the side effects of Noradrenaline Tartrate?

Noradrenaline tartrate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Tachycardia: rapid heart rate due to beta‑1 stimulation. - Headache: result of increased vascular tone. - Anxiety or restlessness: central nervous system activation. - Nausea or vomiting: gastrointestinal irritation. - Peripheral ischemia: reduced blood flow to extremities. - Arrhythmias: irregular heart rhythms.

Serious or Rare Side Effects: - Severe hypertension: excessive rise in blood pressure. - Myocardial infarction: heart attack risk in vulnerable patients. - Tissue necrosis at injection site: extravasation injury. - Pulmonary edema: fluid accumulation in lungs. - Cardiac arrest: sudden loss of heart function. - Severe arrhythmias: life‑threatening rhythm disturbances.

What precautions apply to Noradrenaline Tartrate?

When using Noradrenaline tartrate, clinicians should observe several safety measures. - Monitor blood pressure: adjust infusion to maintain target MAP. - Assess cardiac rhythm: watch for tachyarrhythmias and ischemia. - Avoid extravasation: prefer central venous access and inspect infusion site frequently. - Use with caution in coronary artery disease: risk of myocardial ischemia. - Limit use in severe peripheral vascular disease: risk of limb ischemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

What does Noradrenaline Tartrate interact with?

Noradrenaline tartrate can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Tricyclic antidepressants: additive pressor effect. - Beta‑blockers: may blunt desired increase in cardiac output.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance hypotensive episodes when infusion is tapered. - Calcium channel blockers: potential for additive vasodilation. - Diuretics: may affect intravascular volume and response.

Frequently asked questions

What is Noradrenalina Tartrato Hameln used for?+
Noradrenalina Tartrato Hameln contains noradrenaline tartrate, a vasopressor used in hospitals to raise blood pressure in patients with acute hypotension, septic shock, or cardiogenic shock when rapid circulatory support is required.
How does noradrenaline tartrate work?+
The drug acts as a direct agonist at alpha‑1 adrenergic receptors, causing blood‑vessel constriction and increased systemic vascular resistance. It also modestly stimulates beta‑1 receptors, enhancing heart contractility, together producing a rapid rise in arterial pressure.
What is the usual dose of Noradrenalina Tartrato Hameln?+
The dose is individualized by the treating physician based on the patient’s hemodynamic status, target blood‑pressure goals, and response to therapy. Dosing is typically expressed as a continuous intravenous infusion rate and adjusted in real time.
Is Noradrenalina Tartrato Hameln safe in pregnancy or breastfeeding?+
Safety data in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and it is prescribed by a specialist familiar with its profile.
How do I order Noradrenalina Tartrato Hameln from GNH USA?+
Submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Noradrenalina Tartrato Hameln compare with other vasopressors?+
Noradrenaline is the first‑line vasopressor for most forms of shock because of its potent alpha‑1 activity and relatively predictable effect on blood pressure. Compared with dopamine or phenylephrine, it offers stronger vasoconstriction with less tachyarrhythmia risk, making it preferred in septic shock.
What are the storage and handling requirements for this product?+
The injectable solution should be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the vial. Once removed from refrigeration, use within the time frame specified by the manufacturer.
How is Noradrenalina Tartrato Hameln administered?+
It is given intravenously, usually via a calibrated infusion pump. Administration is performed in a monitored setting such as an intensive‑care unit, with continuous blood‑pressure and cardiac‑rhythm monitoring to allow rapid dose adjustments.
What are the most serious risks to watch for during therapy?+
Clinicians should be alert for severe hypertension, myocardial ischemia or infarction, arrhythmias, tissue necrosis from extravasation, and, in rare cases, pulmonary edema or cardiac arrest. Prompt recognition and dose modification are essential to mitigate these risks.
Who should not receive Noradrenalina Tartrato Hameln?+
Patients with known hypersensitivity to noradrenaline or any excipients, those with uncontrolled severe peripheral vascular disease, or individuals in whom vasoconstriction could worsen tissue perfusion should not be treated with this drug.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Noradrenaline Tartrate
Route
Intravenous Use
Manufacturer
Hameln Pharma Gmbh
Origin
EU

Related products

Cronomir

Cronomir

Noradrenaline Tartrate

Laboratoire Aguettant
EU
L-Noradrenalina Braun

L-Noradrenalina Braun

Noradrenaline Tartrate

B. Braun Medical Lda.
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU
Levophed

Levophed

Noradrenaline Tartrate

Hospira Benelux
EU